Zusammenfassung
In der vorliegenden Arbeit werden 2 Fälle von zunehmender Kallusdichte nach der perkutanen Applikation von 3,5 mg rekombinantem humanem Bone Morphogenetic Protein-7 (rhBMP-7) beschrieben. Beide Patienten wurden nach Osteitis der langen Röhrenknochen (Femur und Tibia) und Segmentresektion mittels Segmenttransport behandelt, wobei jedoch eine Kallusreifung ausblieb. Nach perkutaner Applikation von rhBMP-7 zeigte der Transportkallus beider Patienten eine zunehmende Knochendichte.
Abstract
Two cases of increased bone density after callus distraction are described following percutaneous administration of 3.5 mg recombinant bone morphogenetic protein-7 (rhBMP-7). Both patients underwent segmental resection and segmental transport for osteomyelitis of the long bones (femur and tibia) but no callus maturation occurred. After percutaneous administration of rhBMP-7 the callus density increased in both cases.
Literatur
Yasui N, Kojimoto H, Sasaki K et al (1993) Factors affecting callus distraction in limb lengthening. Clin Orthop 293:55–60
Celeste AJ, Iannazzi JA, Taylor RC et al (1990) Identification of transforming growth factor β family members present in bone inductive protein purified from bovine bone. Proc Natl Acad Sci U S A 87:9843
Wang EA, Rosen V, D’Alessandro J et al (1990) Recombinant human bone morphogenic protein induces bone formation. Proc Natl Acad Sci U S A 87:2220
Wozney JM, Rosen V, Celeste AJ et al (1982) Novel regulators of bone formation: molecular clones and activities. Science 42:1528
Cook SD, Wolfe MW, Slakeld SL, Rueger DC (1995) Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg [Am] 77:734–750
Cook SD, Salkeld SL, Brinker MR et al (1998) Use of an osteoinductive biomaterial (rhOP1) in healing large segmental bone defects. J Orthop Trauma 12:407–412
Cook SD, Baffes GC, Wolfe MW et al (1994) The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg [Am] 76:827–838
Zakhary K, Motakis D, Hamdy RH et al (2005) Effect of rh BMP-7 on bone density during distraction osteogenesis of the rabbit mandible. J Otolaryngol 34(6):405–417
Mizumoto Y, Moseley T, Drews M et al (2003) Acceleration of regenerate ossification during distraction osteogenesis with recombinant human BMP-7. J Bone Joint Surg [Am] 85-A (suppl 3):124–130
Sciadini MF, Johnson KD (2000) Evaluation of rhBMP-2 as a bone graft substitute in canine segmental defect model. J Orthop Res 18:289–302
Li RH, Bouxsein ML, Blake CA et al (2003) rhBMP-2 injected in calcium phosphate paste (alpha BSM) accelerates healing in the rabbit ulnar osteotomy model. J Orthop Res 21:997–1004
Tiedemann JJ, Connolly JF, strates BS, Lippiello L (1991) Treatment of nonunion by percutaneous injection of bone marrow and demineralized bone matrix – an experimental study in dogs. Clin Orthop Relat Res 268:294–302
Connolly JF, Guse R, Tiedemann J, Dehene R (1991) Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 266:259–270
Terheyden H, Wang H, Warnke PH et al (2003) Acceleration of callus maturation using rhOP-1 in mandibular distraction osteogenesis in a rat model. Int J Oral Maxillofac Surg 32(5):528–533
Anticevic D, Jelic M, Vukicevic S (2006) Treatment of a congenital pseudarthrosis of the tibia by osteogenic protein-1 (bone morphogenetic protein-7): a case report. J Pediatr Orthop B 15(3):220–221
Einhorn TA, Majeska RJ, Mohaideen A et al (2003) A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair. J Bone Joint Surg [Am] 85-A(8):1425–1435
Edwards RB, Seeherman HJ, Bogdanske JJ et al (2004) Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy. J Bone Joint Surg [Am] 86-A(7):1425–1438
Yeung HY, Lee SK, Fung KP, Leung KS (2001) Expression of basic fibroblast growth factor during distraction osteogenesis. Clin Orthop Relat Res (385):219–229
Canalis E, Centrella M, MvCarthy TL (1988) Effects of basic fibroblast growth factor on bone formation in vitro. J Clin Invest 81:1672–1577
Nakashima K, Yanagisawa M, Arakawa H et al (1999) synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. Science 284:479–482
Janknecht R, Hunter T (1999) Nuclear fusion of signaling pathways. Science 284:443–444
Kingsley DM (1994) The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev 8:133–146
Massague J, Attisano L, Wrana JL (1994) The TGF-β family and its composite receptors. Trends Cell Biol 4:172–178
Zioncheck TF, Chen SA, Richardson L et al (1994) Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta 1 after topical and intravenous administration in male rats. Pharm Res 11(2):213–220
Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA (1999) Growth factor regulation of fracture repair. J Bone Miner Res 14(11):1805–1815
Friedlaender GE, Perry CR, Cole JD et al (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg [Am] 83 (suppl 1):S151–S158
Zapf J, Hauri C, Waldvogel M, Froesch ER (1986) Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 77(6):1768–1775
Giannoudis PV, Einhorn TA, Schmidmaier G, Marsh D (2008) The diamond concept – open questions. Injury 39S2:5–8
Zimmermann G, Moghaddam A, Wagner C et al (2006) Klinische Erfahrungen mit bonemorphogenetic protein 7 (BMP7) bei Pseudarthrosen langer Röhrenknochen. Unfallchirurg 109(7):528–537
Interessenkonflikt
Keine Angabe.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Högel, F., Militz, M., Bühren, V. et al. Perkutane Applikation von rekombinantem humanem Bone Morphogenetic Protein-7 (rhBMP-7) nach Kallusdistraktion. Unfallchirurg 114, 167–171 (2011). https://doi.org/10.1007/s00113-010-1815-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00113-010-1815-7